Types of Membership
Membership in the NYUCI is open to all members of the New York University full-time faculty. All schools, institutes, and centers of New York University are eligible to participate, as are the clinical affiliates of the NYU School of Medicine. These include the facilities of the NYU Hospitals Center, Bellevue Hospital Center, Woodhull Medical Center, and the Veterans Administration NY Harbor Healthcare System.
Full Members will meet one or more of the following criteria
- Serve as a Principal Investigator on cancer-related research grants funded by the National Cancer Institute (NCI) or an NCI approved peer-reviewed agency or organization. Grants must be current or applications submitted within the last three years.
- Lead multiple clinical trials within a disease program
- Serve as committee chair on NCI-sponsored clinical research committees.
- Hold Cancer Institute leadership position (For example- research programs or committees)
Associate Members must fit at least one of the following criteria:
- New faculty member within 3 years who has submitted cancer-related research grants funded by the National Cancer Institute (NCI) or an NCI approved peer-reviewed agency or organization
- Shared Resource Directors
- Faculty member who has an active role in program development, and/or the design and implementation of clinical trials (For example- patient accrual)
Collaborating Members will meet the following criteria:
- Spend at least 50% of their clinical care with cancer patients
- Participate in the overall interdisciplinary research environment
NYUCI membership is reviewed annually by the NYUCI Membership Committee based on membership criteria. All members must annually submit updated NIH biosketches for funding and publication evaluation. Membership status may change after annual review, as any Associate and Collaborating Member may become a Full Member if they fit the aforementioned criteria. Members may also become inactive.
Full Members will become inactive if they:
- Do not have cancer-related NCI or NCI approved peer-reviewed funding for 3 years
- Do not have programmatic publications for 3 years
- Do not attend program meetings
- No longer hold a Cancer Institute leadership position
- Have not led clinical trials within a disease program within the last 3 years
- No longer hold a committee chair position on NCI-sponsored clinical research committee
Associate Members will become inactive if he or she no longer is a Shared Resource Director, does not attend program meetings, or no longer participates in the design or implementation of clinical trials.
Collaborating Members will become inactive if he or she spends less than 50% of their clinical time with cancer patients, or does not attend program meetings.